Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
310 participants
OBSERVATIONAL
2022-06-02
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Examination of Electroencephalography Signals of Individuals With Different Eating Disorders
NCT05555277
The Experience of Affective Touch in Anorexia Nervosa
NCT05756530
Nutritional Rehabilitation and Markers of Severity in Anorexia Nervosa
NCT05627583
Anorexia Nervosa and Its Effects on Brain Function, Body Metabolism and Their Interaction in Adolescents
NCT05357053
Geriatric Anorexia Study 2.0
NCT05211973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Volunteering to participate in the study,
* Being conscious and not having communication problems,
* Having a Charlson comorbidity index of 1 or higher and/or a diagnosis of hypertension,
* Being fed orally.
Exclusion Criteria
* Presence of neurological or muscular disease that prevents swallowing,
* Being fed by nasogastric tube, percutaneous endoscopic gastrostomy or intravenous nutrition,
* Using drugs that affect appetite (corticosteroid, cancer chemotherapy digoxin, opioids, serotonin reuptake inhibitors, topiramate),
* Using appetizers (megestrol acetate, dronabinol, mirtazapine, growth hormone analogue),
* Having an active cancer disease,
* Major neuro-psychiatric disease (Alzheimer's, dementia, major depression, mania, psychosis, etc.),
* Presence of acute infection,
* Not having sufficient communication skills (Mini Mental Test score below 24 points).
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elif Yıldırım Ayaz, M.D.
Role: PRINCIPAL_INVESTIGATOR
Sultan Abdülhamid Training And Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sultan Abdülhamid Training and Research Hospital
Üsküdar, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APETI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.